Besides its impact on tumor cell signaling, sotorasib was also found to restore an efficient immune tumor response (84, 86) as evidenced by increased T-cell infiltration and immune effectors including macrophages, CD103+ dendritic cells and CD4+/CD8+ T-cells (Table 1) (83). The gene discussed is ITGAE; the disease is neoplasm.